4.7 Article

Prostate cancer: ESMO Consensus Conference Guidelines 2012

期刊

ANNALS OF ONCOLOGY
卷 24, 期 5, 页码 1141-1162

出版社

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mds624

关键词

consensus; ESMO; prostate cancer

类别

资金

  1. Abbott Pharmaceuticals
  2. GlaxoSmithKline
  3. Lilly Pharmaceuticals
  4. Cancer Research UK [10588] Funding Source: researchfish

向作者/读者索取更多资源

The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据